Services Design Development Scientific Advice Project Management QA – Quality Assurance Monitoring Clinical Performance Data Management/eTrials Biostatistics Medical Writing Expert Statement Expertise Pharmacokinetics BA/BE Interactions Oncological trials Ophthalmological trials Inhalatives Transdermal Therapeutic Systems Children Sexual Hormones Therapeutic Expertise Clinical Development Phase I Phase II / Proof of Concept Phase III in OTC Phase III Non-Interventional Magnetic Marker Monitoring Medical Devices Nutrition Studies Clinical Pharmacology Unit Location Plan Capacity Technical Monitoring Ophthalmology Gynaecology Intensive Assessment Unit Clean Room Area Archive About Us Goals and Visions Our Experts Science Quality Library Presentations Library Publications Locations Career News German Pharm-Tox Summit 2017 in Heidelberg 2nd part of Introductory Course in Exploratory Medicines Development scheduled for February 2017 Introductory Course in Exploratory Medicines Development – taking place in our offices in Oberursel! 2nd Global Bioequivalence Harmonisation Initiative – a great success Quality Management Systems in Early Phase Trials Trial in drug-induced xerostomia published Probanden The SocraTec Family SocraTec C&S SocraMetrics Cooperations
Clinical trials Sequential designs Gynaecological trials Pituitary Product development Statistical programming CRF Biopharmaceutical Scientific advice Competence Dry eye Oncological patients Inhalatives Clinical development program Adrenocortical OTC Metered dose inhaler Oncology Network Intensive assessment station CDSIC Legal representative Sore throat IB HPA axis Dry powder inhaler Early phase Phase IV Phase IIa trials Authorities Centralised procedure Uveitis Pharmacokintetics Quality Management System Sample size estimation Design development FIM Axis PASS Auditing Highly variable drugs ICF Clinical study Biosimilars IVIVC Immunogenicity Legal Information Bioavailability Xerostomia HRT MDI EMA Rhine Main area US FDA Subcontractor qualification Ocular tolerability Biopharmaceutics Hypothalamic Quality Assurance Referral system Patch Common cold Cardiovascular surveillance Biometrics Patients Recruitment rates Pharmacology Monitoring Quality IMPD COPD TTS Audit US CFR 21 Part 11 Glaucoma Standardisation Oncologic network Data Management Plan Eye disease Training Dermal irritation Informed Consent Procedure DUS Slit lamp microscopy Feasibility Creativity In vitro in vivo correlation Degeneration Experience WinNonlin CRA Phase III Non interventional Project Management Clinical Monitoring Standard operating procedure Central surveillance system Ovulation inhibition Safety Pragmatism Dose linearity Patch adhesion Life cycle management Anaesthesiologist Good Clinical Practice DPI Post authorisation Cough Pharmacodynamic studies Transdermal therapeutic system Statistical services Absorption Statistical Analysis Plan Children SOP based Clinical pharmacology unit HTA CDASH Bioequivalence MMM MCID Pilot study Patient recruitment Efficacy Protocol Allergy FDA Endpoint Spacious archive Lung Sensitisation trials Edema PAES Elpro Ophthalmological trials DFI GLP Healthy subjects SocraTec C&S Phase I Charcoal NIS Phase I Unit CDM First in human Pharmacokinetics CDISC SAS SDV Phase II Drug Food Interaction Drug Drug Interaction Contraception GCP training Protocol development Female adolescents Data Validation Plan Steady state Paediatricians Thuringia Phase IIb trials Data management Investigators brochure IEC Pulse oximetry plethysmography Database ANVISA Local tolerability Expert Inspection Absorption windows AGAH DDI Asthma ADAM Ophthalmologist Macular CRO Hormone replacement therapy Source Data Verification Ophthalmology Scientific expertise GCP Postmenopausal women Consultancy Copyright  
 
Menu

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All fine on front page